Buprenorphine percutaneous absorption preparation

Details Buprenorphine percutaneous absorption preparation Buprenorphine percutaneous absorption preparation

1997-07-18

2000-07-18

Brouillette, D. Gabrielle

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Web, sheet or filament bases; compositions of bandages; or...

424449, A61F 1302

Patent

active

060904054

ABSTRACT:
Disclosed is a buprenorphine percutaneous absorption preparation comprising a backing having formed on one side thereof a pressure-sensitive adhesive layer containing at least one of buprenorphine and a salt thereof, wherein the pressure-sensitive adhesive layer contains an acrylic copolymer and crosslinked acrylic copolymer particles. The buprenorphine percutaneous absorption preparation has excellent pressure-sensitive adhesive characteristics and exerts excellent percutaneous absorption property.

REFERENCES:
patent: 4626539 (1986-12-01), Aungst
patent: 4806341 (1989-02-01), Chien
patent: 4844903 (1989-07-01), Seth
patent: 5026556 (1991-06-01), Drust
patent: 5069909 (1991-12-01), Sharma
patent: 5149538 (1992-09-01), Granger
patent: 5225199 (1993-07-01), Hidaka
patent: 5238933 (1993-08-01), Catz
patent: 5240711 (1993-08-01), Hille
patent: 5240932 (1993-08-01), Morimoto et al.
patent: 5336210 (1994-08-01), Hidaka et al.
patent: 5618555 (1997-04-01), Tokuda et al.

Affiliated with

Also associated with

Rating

Buprenorphine percutaneous absorption preparation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Buprenorphine percutaneous absorption preparation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Buprenorphine percutaneous absorption preparation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2033929